I'm pretty sure the if "every sell-side analyst on Wall Street understands that Teva’s Lovenox is DoA" they wouldn't constantly inject it in their evaluations and Momenta write-ups.
Yeah, but what Dew is saying is that they DON'T inject that opinion into their write-ups, not that they do!